US drug companies and the NHS

Is Britain's health service really up for sale? Ahead of a general election in the UK, Ed Butler looks at why the NHS probably gets a good deal on drug prices compared with other countries, and why US drug companies might want the health service on the table in any post-Brexit trade deal between the US and the UK. We hear from the BBC's health editor Hugh Pym, US pharmaceutical industry analyst Nielsen Hobbs and Professor Allyson Pollock, director of the Institute of Health and Society at Newcastle University.

(Photo: Protestors show support for the NHS at a protest in London, Credit: Getty Images)